Lesson 01
Incomplete
FDA Approval Pathways: 510(k), PMA, and De Novo
The pathway you choose determines your timeline, your capital requirements, and what evidence you have to generate before you can sell anything.
Open lesson →Biotech
Regulatory Affairs & FDA Strategy
Understand how FDA clearance and approval actually work so you can build a product strategy that survives regulatory contact.
4 lessons · 52 minutes · Beginner
Lesson 02
Incomplete
Building Your Regulatory Strategy Before You Build Your Product
Regulatory strategy is not a submission exercise. It is a product development constraint that should be set before the first design decision.
Open lesson →Lesson 03
Incomplete
Working with Regulatory Consultants and Managing the FDA Relationship
FDA is not an obstacle to negotiate around. It is a long-term regulator relationship that rewards consistency, transparency, and preparation.
Open lesson →Lesson 04
Incomplete
Post-Market Surveillance, Adverse Event Reporting, and Compliance
FDA clearance is not the end of regulatory work. It is the beginning of the obligations that can end a company if they are not managed.
Open lesson →